Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

USV PRIVATE LIMITED

Home Clinical Trial Sponsors and OrganizationsUSV PRIVATE LIMITED

USV PRIVATE LIMITED

Arvind Vithal Gandhi Chowk, Mumbai, Maharashtra, India

Also known as:

USV

usv private limited, daman

usv limited

Share to Twitter Share to Facebook Share to LinkedIn Share to Reddit

Clinical Trials

9

4 active

Approvals

45

Total approvals

Agencies

3

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Share

Phase 4

2

22.2%

Phase 2

1

11.1%

Phase 3

1

11.1%

Unknown

1

11.1%

Trial Status Distribution

Active, not recruiting

1

11.1%

Completed

2

22.2%

Not yet recruiting

3

33.3%

Recruiting

2

22.2%

Unknown

1

11.1%

Clinical Trials

Trials sponsored by this organization (9)

Studying the Effect of Rosuvastatin in Patients with Early Signs of Artery Narrowing (Atherosclerosis) - ROSE Trial

Not yet recruiting

May 2025160 participants

To evaluate the demographic characteristics, clinical parameters, and treatment pattern of FDC(Dapagliflozin 10 mg, Metformin 500mg and Vildagliptin 100mg SR) versus FDC(Dapagliflozin,Metformin)and FDC (Dapagliflozin,Vildagliptin SR).

Not yet recruiting

May 2025100 participants

Treatment of Type 2 Diabetes with Vildagliptin 100 mg SR tablet (Jalra-OD).

Aug 2023340 participants

A Prospective study Vildagliptin 100 mg Sustained Release Tablet once daily compared to Sitagliptin 100 mg Tablet in patients with Type 2 diabetes mellitus

Jul 2023132 participants

Assessing the differential benefits of various anti diabetic agents among individuals with novel subtypes of diabetes

Mar 2021576 participants

Management of Type II diabetes mellitus in Indian population

Not yet recruiting

Dec 20188,500 participants

A study to assess the safety and efficacy of USVCAP in patients with type II Diabetes Mellitus uncontrolled with Metformin Hydrochloride treatment.

Jul 2018195 participants

Comparing the Safety and Efficacy of USV Pegfilgrastim and NeulastaÂ® in Breast Cancer Patients

Active, not recruiting

Nov 2016120 participants

Page 1 of 2

Approvals

Approvals by Agency

FDA

Food and Drug Administration

4

Approvals

PHILIPPINES

Philippines FDA

23

Approvals

NPRA

National Pharmaceutical Regulatory Agency

18

Approvals

Recent Approvals

MADEX - Sugammadex Solution for Injection 100 mg/ml

DYNACARD - 150 (Irbesartan Tablets 150 mg)

Glycomet-850 (Metformin Tablets BP 850mg)

Zolex 4mg -Zoledronic Acid Injection 4 mg/5 ml (Concentrate for solution for intravenous infusion)

Ecoxi-120 (Etoricoxib 120mg Film Coated Tablet)

Glycomet - 500 SR (Metformin Hydrochloride Sustained Release Tablets 500 mg)

Filpegla 6 mg / 0.6 mL Solution for Injection in Pre-filled Syringe

Valentron 0.25mg/5ml Solution for Injection

UNIPAL Palonosetron Hydrochloride 250 micrograms solution for injection

XAVI 2.5 mg Film-Coated Tablets

News

No news articles found

On this page

Overview
Clinical Trials9
Approvals45
News

Back to Organizations